JanOne Inc. (JAN) Stock

JanOne Inc., a clinical-stage biopharmaceutical company, is dedicated to identifying, acquiring, licensing, developing, partnering, and commercializing innovative therapies that offer non-opioid and non-addictive solutions for pain management and addiction treatment. The company operates through three distinct segments: Biotechnology, Recycling, and Technology. Its flagship product candidate, JAN101, represents a significant advancement a patented oral and sustained release formulation of sodium nitrite designed to alleviate pain by addressing poor blood flow in patients with diabetes or peripheral artery disease.

In addition to its pioneering work in biotechnology, JanOne Inc. provides comprehensive appliance recycling and replacement services, catering primarily to utilities and sponsors of energy efficiency programs. This segment underscores the company's commitment to sustainability and environmental responsibility. Furthermore, JanOne designs, develops, and markets cellular transceiver modules and related wireless services, contributing to advancements in telecommunications technology.

Formerly known as Appliance Recycling Centers of America, Inc., JanOne Inc. underwent a strategic transformation and rebranding in September 2019 to better reflect its expanded focus on biopharmaceutical innovations and diverse technological ventures. With a founding in 1976 and headquartered in Las Vegas, Nevada, the company combines decades of experience with a forward-looking approach to address critical medical needs and technological advancements.

JanOne Inc. remains dedicated to advancing its pipeline of therapeutic solutions through ongoing research and development initiatives. By leveraging its multidimensional expertise across biotechnology, recycling, and technology sectors, the company aims to deliver impactful treatments and sustainable technological solutions that improve quality of life and meet evolving market demands.